Abstract:BACKGROUND & AIMS Agents designed to block or alter cytokinesis can kill or stop proliferation of cancer cells. We aimed to identify cytokinesis-related proteins that are overexpressed in hepatocellular carcinoma (HCC) cells and might be targeted to slow liver tumor growth. METHODS Using the Oncomine database, we compared the gene expression patterns in 16 cancer microarray datasets and assessed gene enrichment sets using gene ontology. We performed immunohistochemical analysis of an HCC tissue microarray and identified changes in protein levels that are associated with patient survival times. Candidate genes were overexpressed or knocked down with small hairpin RNAs in SMMC7721, MHCC97H, or HCCLM3 cell lines; we analyzed their proliferation, viability, and clone-formation ability and their growth as subcutaneous or orthotopic xenograft tumors in mice. We performed microarray analyses to identify alterations in signaling pathways and immunoblot and immunofluorescence assays to detect and localize proteins in tissues. Yeast 2-hybrid screens and mass spectrometry combined with co-immunoprecipitation experiments were used to identify binding proteins. Protein interactions were validated with co-immunoprecipitation and proximity ligation assays. Chromatin immunoprecipitation, promoter luciferase activity, and quantitative real-time polymerase chain reaction analyses were used to identify factors that regulate transcription of specific genes. RESULTS The genes that were most frequently overexpressed in different types of cancer cells were involved in cell division processes. We identified 3 cytokinesis-regulatory proteins among the 10 genes most frequently overexpressed by all cancer cell types. Rac GTPase activating protein 1 (RACGAP1) was the cytokinesis-regulatory protein that was most highly overexpressed in multiple cancers. Increased expression of RACGAP1 in tumor tissues was associated with shorter survival times of patients with cancer. Knockdown of RACGAP1 in HCC cells induced cytokinesis failure and cell apoptosis. In microarray analyses, we found knockdown of RACGAP1 in SMMC7721 cells to reduce expression of genes regulated by yes-associated protein (YAP) and WW domain containing transcription regulator 1 (WWTR1 or TAZ). RACGAP1 reduced activation of the Hippo pathway in HCC cells by increasing activity of RhoA and polymerization of filamentous actin. Knockdown of YAP reduced phosphorylation of RACGAP1 and redistribution at the anaphase central spindle. We found transcription of the translocated promoter region, nuclear basket protein (TPR) to be regulated by YAP and coordinately expressed with RACGAP1 to promote proliferation of HCC cells. TPR redistributed upon nuclear envelope breakdown and formed complexes with RACGAP1 during mitosis. Knockdown of TPR in HCC cells reduced phosphorylation of RACGAP1 by aurora kinase B and impaired their redistribution at the central spindle during cytokinesis. STAT3 activated transcription of RACGAP in HCC cells. CONCLUSIONS In an analysis of gene expression patterns of multiple tumor types, we found RACGAP1 to be frequently overexpressed, which is associated with shorter survival times of patients. RACGAP1 promotes proliferation of HCC cells by reducing activation of the Hippo and YAP pathways and promoting cytokinesis in coordination with TPR.

Rac GTPase activating protein 1 promotes the glioma growth by regulating the expression of MCM3

Targeting RACGAP1 Suppresses Growth Hormone Pituitary Adenoma Growth

Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo

RAB1A Regulates Glioma Cellular Proliferation and Invasion Via the Mtor Signaling Pathway and Epithelial-Mesenchymal Transition.

Expression of RACGAP1 in High Grade Meningiomas: a Potential Role in Cancer Progression

RACGAP1 drives proliferation, migration and invasion and suppresses autophagy of gastric cancer cells via inhibiting SIRT1/Mfn2

Role of Rac1 in glioma stem cell migration and invasion

RacGAP1 Promotes the Malignant Progression of Cervical Cancer by Regulating AP-1 Via Mir-192 and P-Jnk

RACGAP1 promotes lung cancer cell proliferation through the PI3K/AKT signaling pathway

Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.

Overexpressed Mirna-137 Inhibits Human Glioma Cells Growth by Targeting Rac1

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma

Long non-coding RNA RMRP promotes human glioma tumor progression via miR-466/CXCR4 pathway

Impact of RANGAP1 SUMOylation on Smad4 nuclear export by bioinformatic analysis and cell assays

RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness

RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma

Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma

Upregulated YB-1 Protein Promotes Glioblastoma Growth Through a YB-1/CCT4/mLST8/mTOR Pathway

Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma

NKCC1 Promotes EMT-like Process in GBM Via RhoA and Rac1 Signaling Pathways.

Rac GTPase Activating Protein 1 Promotes Gallbladder Cancer Via Binding DNA Ligase 3 to Reduce Apoptosis